NCT04651140 is a NA clinical trial of aerobic exercise in Parkinson's Disease, sponsored by The First Hospital of Jilin University.

Who is sponsoring NCT04651140?

NCT04651140 is sponsored by The First Hospital of Jilin University.

What drugs are being tested in NCT04651140?

Interventions in NCT04651140: aerobic exercise.

What condition does NCT04651140 study?

NCT04651140 studies Parkinson's Disease, Physical Exercise.

Is NCT04651140 still recruiting?

NCT04651140 is currently status unknown. Last updated 5 January 2021.

Last reviewed 2021-01-05 · How we verify

NCT04651140

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Research on the Effect and Mechanism of Aerobic Exercise on PD

Status unknown NA Last updated 5 January 2021

What this trial tests

NA trial testing aerobic exercise in Parkinson's Disease in 30 participants. Status unknown.

Timeline

13 October 2020

Primary endpoint
30 October 2021

30 October 2021

Quick facts

Lead sponsor	The First Hospital of Jilin University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	30
Start date	13 October 2020
Primary completion	30 October 2021
Estimated completion	30 October 2021
Sites	1 location across China

Drugs / interventions tested

aerobic exercise — full drug profile →

Conditions studied

Parkinson's Disease — all drugs for Parkinson's Disease →
Physical Exercise — all drugs for Physical Exercise →

Sponsor

The First Hospital of Jilin University

Who can join

Adults 55 to 65, any sex, with Parkinson's Disease or Physical Exercise. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This trial is expected to recruit patients with primary Parkinson's disease and give them four consecutive weeks of aerobic exercise to observe its effect on Parkinson's disease and explore its mechanism

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Clinical Trials of Non-Coding RNAs as Diagnostic and Therapeutic Biomarkers for Central Nervous System Injuries.
Wang H, Wang Q, Xiao X, Luo X, et al · · 2023 · PMID 36443964 · DOI 10.2174/1570159x21666221128090025

Verify or expand the search:

Other trials of aerobic exercise

Trials testing the same drug.

NCT07326228 — Effect of Exercises on Ventilatory Function in Adult With TOF · NA · not yet recruiting
NCT07139275 — Insulin Sensitivity and Testosterone Response to Aerobic Exercise Versus Added Sugar Elimination in Polycystic Ovary Syn · NA · not yet recruiting
NCT07073716 — TAC, SOD and MDA Responses to Aerobic Exercise Versus Phoenix Seed in Obese Sedentary Females · NA · not yet recruiting
NCT07003711 — Effects of Progressive Muscle Relaxation Training Applied in Addition to Aerobic Exercise Training in Individuals With M · NA · completed
NCT06838299 — Two Different Renal Rehabilitation Protocols in Hemodialysis Patients · NA · completed

Other recruiting trials for Parkinson's Disease

Currently open trials in the same condition.

NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
NCT07330258 — A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite · recruiting
NCT07384429 — Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease · Phase 4 · recruiting
NCT07384442 — Effects of Targeted Temporal Interference Stimulation of Cerebellar Nuclei on Tremor and Gait Disturbance in Parkinson's · NA · recruiting
NCT06562569 — Non-invasive VNS for PD Gait · NA · recruiting

Other The First Hospital of Jilin University trials

Trials by the same sponsor.

NCT07308340 — Rapid Identification of Infectious Pathogens in Severe Pneumonia Guided by Bronchoscopic Imaging and Lung CT · not yet recruiting
NCT07369531 — The Impact of Two-Stage Turnbull-Cutait Pull-Through Coloanal Anastomosis on Stoma-free Survival in Low Rectal Anal-pres · NA · recruiting
NCT07414160 — Association Between Dynamic Prealbumin Trajectories and Prognosis in Critically Ill Patients · not yet recruiting
NCT07440368 — Enterocyte Injury and Acute Gastrointestinal Dysfunction in Critical Illness · not yet recruiting
NCT07505472 — Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Wit · Phase 2, PHASE3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04651140 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The First Hospital of Jilin University
Last refreshed: 5 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04651140.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing